posted on Oct, 7 2009 @ 11:25 PM
Hello ATS. Follow me as I connect the dots.
#1 H1N1 novel influenza. This flu will work well not only because it is highly contagious, but also because it is infecting people many months before
a typical flu season.
#2 Have a months long scare/marketing campaign to hype the importance of being
#3 Rush the product (vaccine) through testing and approval a
five months after discovery of the novel flu.
O.k, now this is where it gets interesting. The first batch of vaccine to be released to the population (mainly to healthcare professionals) is the
nasal vaccine FluMist LAIV. (Live Attenuated Influenza Vaccine
FluMist first available vaccine
Now here is the theory part ladies and gentlemen... The reasoning behind releasing this vaccine first may be the LIVE VIRUS
it. Theoretically, big pharma could release a more virulent, manufactured strain on the population through viral shedding of those who received the
fist batches of vaccine.
The old "switcharoo". This flu could be engineered to act any way they want it to. These "shedding" individuals are
the key to selling billions
of vaccines. They spread the manufactured strain of the
According to the Center for Disease Control's website...
Nasal-Spray Flu Vaccine Live Attenuated Influenza Vaccine LAIV CDC
Minnesota Department of Health
Can people receiving the nasal-spray flu vaccine LAIV (FluMist®) pass the vaccine viruses to others?
In clinical studies, transmission of vaccine viruses to close contacts has occurred only rarely. The current estimated risk of getting infected with
vaccine virus after close contact with a person vaccinated with the nasal-spray flu vaccine is low (0.6%-2.4%).
Is shedding the virus a problem for health care workers?
By law the FluMist package insert must state that a person can shed the virus for up to three weeks, but shedding alone should not be equated with
person-to-person transmission. In fact studies have found that it is very rare. In a study designed to maximize the chance of detecting vaccine virus
transmission, conducted in a Finnish daycare, one child shed the virus for 21 days. Other children in this study shed the virus a mean of 7.6 days. An
additional small study of 40 adults conducted since licensure found that only 50% of the adults were shedding the virus from the influenza vaccine on
day three after vaccination; one adult shed the virus on day seven as well.
What the CDC and MDH are stating here should shock people. They are saying the live virus contained within the FluMist vaccine can be shed by up to
50% of those who receive it. Moreover, those shedding the virus can then infect up to 2.4 percent of people whom they have contact with. Do the math.
Could this be the money making scheme of big pharma?
Thank you for taking the time to hear me out. Please discuss.
[edit on 7-10-2009 by METACOMET]